Skip to content

Nilvadipine

CARDIOVASCULAR SYSTEM

Also known as: FR-34235, nivadil, nivaldipine

YEAR INTRODUCED approvedATC C08CA10

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Nilvadipine is a drug catalogued in DrugCentral. It was first approved by the YEAR INTRODUCED in 1992. DrugCentral lists 4 molecular targets, including CACNG1, CACNA1C and CACNA1D.

  • Molecular targets: CACNG1, CACNA1C, CACNA1D and CACNA1D|CACNA1C (4 listed in DrugCentral).
  • ATC code: C08CA10 (Dihydropyridine derivatives).
  • Molecular formula: C19H19N3O6; molecular weight 385.38 g/mol.

Mechanism & targets

Molecular targets (4)

TargetGeneActionActivity
Voltage-dependent calcium channel gamma-1 subunitCACNG1unknown—
Voltage-dependent L-type calcium channel subunit alpha-1CCACNA1Cunknown—
Voltage-dependent L-type calcium channel subunit alpha-1DCACNA1Dunknown—
Voltage-gated L-type calcium channelCACNA1D|CACNA1Cblocker—

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
1992-01-01YEAR INTRODUCED——

ATC classification

ATC codeTherapeutic hierarchy
C08CA10CARDIOVASCULAR SYSTEM › CALCIUM CHANNEL BLOCKERS › SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS › Dihydropyridine derivatives

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Nilvadipine is on its molecule page.

Molecular formulaC19H19N3O6
Molecular weight385.38 g/mol
CAS number75530-68-6
InChIKeyFAIIFDPAEUKBEP-UHFFFAOYSA-N
PubChem CID4494
COC(=O)C1=C(NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)C)C#N

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

How does Nilvadipine work?

Its molecular targets in DrugCentral include CACNG1, CACNA1C, CACNA1D and CACNA1D|CACNA1C (blocker).

When was Nilvadipine first approved?

Nilvadipine was first approved by the YEAR INTRODUCED in 1992.

What is the chemical formula of Nilvadipine?

Nilvadipine has the molecular formula C19H19N3O6 and a molecular weight of 385.38 g/mol.

Browse: all drugs starting with N · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval1992-01-01
AgencyYEAR INTRODUCED
Targets4
Indications0
FormulaC19H19N3O6
DrugCentral ID1934
Interactive profile